Related Experiment Video
Updated: Apr 16, 2026

05:06
Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
16.2K
Tumor-targeting bioluminescent bacteria for in vivo imaging
Chenghao Ma1, Jingxi Liu2, Hongjing Liu3
1State Key Laboratory of Microbial Technology, Institute of Microbial Technology, Helmholtz International Lab for Anti-Infectives, Shandong University-Helmholtz Institute of Biotechnology, Shandong University, Qingdao 266237, China.
Engineering Microbiology
|April 15, 2026
Summary
Researchers optimized bacteria (Escherichia coli Nissle 1917) for cancer therapy imaging. They developed new bioluminescent strains for real-time monitoring of bacteria in live mice, enhancing cancer research tools.
Area of Science:
- Microbiology
- Biotechnology
- Cancer Research
Background:
- Bacteria-mediated cancer therapies are advancing.
- Escherichia coli Nissle 1917 (EcN) shows promise for cancer treatment.
- Enhanced visualization tools are needed for real-time monitoring of EcN in vivo.
Purpose of the Study:
- To screen and optimize visualization systems for non-invasive in vivo bioluminescence imaging of EcN.
- To develop recombinant EcN strains with enhanced bioluminescent properties.
Main Methods:
- Created three series of recombinant EcN strains expressing Gaussia luciferase (Gluc), Renilla luciferase (Rluc), and NanoLuc (Nluc) and their mutants.
- Tested bioluminescence of these strains with different coelenterazine (CTZ) substrates in vitro and in vivo.
- Evaluated signal strength, duration, and spectral properties of the bioluminescence.
Main Results:
- Identified multiple effective bioluminescent EcN strain-substrate pairs.
- Achieved stronger, longer-lasting, or red-shifted bioluminescence signals.
- Demonstrated potential for optical tumor-targeting systems.
Conclusions:
- Optimized EcN visualization systems enable effective in vivo bioluminescence imaging.
- These systems offer versatile tools for studying bacteria-mediated cancer therapy.
- The developed strains are valuable for research in intestinal diseases as well.

